The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/18449207

Download in:

View as

General Info

PMID
18449207